🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of acetaminophen, asserting the corporations hid potential risks that the drug created to children's brain development.

The lawsuit follows a month after President Donald Trump publicized an unsubstantiated connection between using acetaminophen - also known as paracetamol - during pregnancy and autism in children.

The attorney general is suing J&J, which once produced the drug, the only pain reliever recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "betrayed America by profiting off of discomfort and marketing drugs without regard for the dangers."

Kenvue says there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking millions to line their pockets," Paxton, from the Republican party, said.

The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its website, Kenvue also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that indicates a verified association between using paracetamol and autism."

Groups acting on behalf of doctors and medical practitioners agree.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is among limited choices for pregnant women to manage pain and elevated temperature, which can create serious health risks if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in gestation, no reliable research has successfully concluded that the use of paracetamol in any period of gestation causes brain development issues in offspring," the group commented.

The lawsuit cites recent announcements from the former administration in asserting the drug is reportedly hazardous.

In recent weeks, the former president raised alarms from medical authorities when he advised expectant mothers to "resist strongly" not to use acetaminophen when ill.

Federal regulators then published an announcement that doctors should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism spectrum disorder in young ones has remains unverified.

The Health Department head RFK Jr, who supervises the FDA, had vowed in spring to initiate "comprehensive study program" that would establish the cause of autism spectrum disorder in a short period.

But authorities warned that discovering a sole reason of autism - thought by researchers to be the result of a complex mix of genetic and environmental factors - would prove challenging.

Autism is a category of permanent neurological difference and disability that influences how individuals encounter and interact with the world, and is diagnosed using physician assessments.

In his legal document, the attorney general - a Trump ally who is seeking the Senate - asserts the manufacturer and J&J "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case seeks to make the firms "eliminate any promotional materials" that asserts acetaminophen is reliable for women during pregnancy.

The court case echoes the grievances of a assembly of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in two years ago.

The court dismissed the case, declaring studies from the plaintiffs' authorities was not conclusive.